Concentration of fractional excretion of nitric oxide (FENO): A potential airway biomarker of restored CFTR function Kavitha Kotha, Rhonda D. Szczesniak, Anjaparavanda P. Naren, Matthew C. Fenchel, Leo L. Duan, Gary L. McPhail, John P. Clancy Journal of Cystic Fibrosis Volume 14, Issue 6, Pages 733-740 (November 2015) DOI: 10.1016/j.jcf.2015.07.002 Copyright © 2015 Terms and Conditions
Fig. 1 CONSORT flowchart diagram relevant to this study. (A) Cohort 1; (B) Cohort 2. Journal of Cystic Fibrosis 2015 14, 733-740DOI: (10.1016/j.jcf.2015.07.002) Copyright © 2015 Terms and Conditions
Fig. 2 Individual changes in (A) FENO, (B) FEV1 % predicted, (C) sweat chloride, and (D) weight in CF patients with gating mutations, before and after one month of ivacaftor therapy. Each curve is from an individual patient, with values to the left before ivacaftor and values to the right after one month of ivacaftor. Genotypes of the five individual subjects were S549N/S549N (CF01-03), S549R/F508del (CF04), and G178R/F508del (CF05). Journal of Cystic Fibrosis 2015 14, 733-740DOI: (10.1016/j.jcf.2015.07.002) Copyright © 2015 Terms and Conditions